首页 › 基金 › ArrowMark Colorado Holdings LLC › KNSA
ArrowMark Colorado Holdings LLC 对 KNSA 的持仓历史
KINIKSA PHARMACEUTICALS INTL · 医疗保健
ArrowMark Colorado Holdings LLC 在 Q3 2026 的 13F 申报中披露持有 KNSA(KINIKSA PHARMACEUTICALS INTL)198,673 股,市值约 US$14.8M,约占其申报组合的 0.70%,在其申报持仓中市值排名第 30 位。 ArrowMark Colorado Holdings LLC 最近 13 个申报季度中有 13 个季度披露了 KNSA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
ArrowMark Colorado Holdings LLC 对 KNSA 的持仓演变
ArrowMark Colorado Holdings LLC 于 Q3 2023 首次披露 KNSA 持仓:760,353 股(约 US$13.2M)。 该持仓在 Q1 2026 达到峰值 316,956 股,市值约 US$15.3M。 在 13 次申报中,ArrowMark Colorado Holdings LLC 1 次增持、11 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 198,673 股、市值约 US$14.8M,环比减持 -16,873 股。。 持仓曾出现大幅变动:Q3 2025 减持约 27% (随后一个季度股价上涨 6%)、Q2 2026 减持约 32% (随后一个季度股价上涨 17%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 760.35K | $13.21M | 新进 |
| Q4 2023 | 714.88K | $12.54M | 减持 |
| Q1 2024 | 666.98K | $13.16M | 减持 |
| Q2 2024 | 608.87K | $11.37M | 减持 |
| Q3 2024 | 531.29K | $13.28M | 减持 |
| Q4 2024 | 521.89K | $10.32M | 减持 |
| Q1 2025 | 535.71K | $11.90M | 增持 |
| Q2 2025 | 465.90K | $12.89M | 减持 |
| Q3 2025 | 340.63K | $13.23M | 减持 |
| Q4 2025 | 333.70K | $13.77M | 减持 |
| Q1 2026 | 316.96K | $15.26M | 减持 |
| Q2 2026 | 215.55K | $13.78M | 减持 |
| Q3 2026 | 198.67K | $14.82M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KNSA 与 13F 数据
KNSA(KINIKSA PHARMACEUTICALS INTL)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 KNSA,申报仓位最大的包括:Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KNSA 的基金
- Rubric Capital Management LP 4.00M 股 · $255.79M · Q2 2026
- BAKER BROS. ADVISORS LP 2.83M 股 · $181.28M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 2.26M 股 · $144.52M · Q2 2026
- Spruce Street Capital LP 918.07K 股 · $68.50M · Q3 2026
- RICE HALL JAMES & ASSOCIATES, LLC 466.05K 股 · $34.77M · Q3 2026
- OBERWEIS ASSET MANAGEMENT INC/ 410.91K 股 · $30.66M · Q3 2026
- ORBIMED ADVISORS LLC 420.60K 股 · $26.90M · Q2 2026
- Penn Capital Management Company, LLC 347.66K 股 · $25.97M · Q3 2026
- Soleus Capital Management, L.P. 246.35K 股 · $15.75M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 202.02K 股 · $15.07M · Q3 2026
更多关于 ArrowMark Colorado Holdings LLC
常见问题
How long has ArrowMark Colorado Holdings LLC held KNSA?
ArrowMark Colorado Holdings LLC has disclosed KNSA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ArrowMark Colorado Holdings LLC's current position in KNSA?
As of Q3 2026, ArrowMark Colorado Holdings LLC holds 198.67K shares of KNSA (KINIKSA PHARMACEUTICALS INTL), valued at $14.82M, representing 0.70% of its reported portfolio and ranking #30.
Has ArrowMark Colorado Holdings LLC been buying or selling KNSA?
In the latest 13F filing (Q3 2026), ArrowMark Colorado Holdings LLC reduced its position in KNSA. The position peaked in Q1 2026 at 316.96K shares.
Which other funds hold KNSA?
Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.